Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
H Cuppens, … , B Nilius, J J Cassiman
H Cuppens, … , B Nilius, J J Cassiman
Published January 15, 1998
Citation Information: J Clin Invest. 1998;101(2):487-496. https://doi.org/10.1172/JCI639.
View: Text | PDF
Research Article Article has an altmetric score of 19

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.

  • Text
  • PDF
Abstract

In congenital bilateral absence of the vas deferens patients, the T5 allele at the polymorphic Tn locus in the CFTR (cystic fibrosis transmembrane conductance regulator) gene is a frequent disease mutation with incomplete penetrance. This T5 allele will result in a high proportion of CFTR transcripts that lack exon 9, whose translation products will not contribute to apical chloride channel activity. Besides the polymorphic Tn locus, more than 120 polymorphisms have been described in the CFTR gene. We hypothesized that the combination of particular alleles at several polymorphic loci might result in less functional or even insufficient CFTR protein. Analysis of three polymorphic loci with frequent alleles in the general population showed that, in addition to the known effect of the Tn locus, the quantity and quality of CFTR transcripts and/or proteins was affected by two other polymorphic loci: (TG)m and M470V. On a T7 background, the (TG)11 allele gave a 2.8-fold increase in the proportion of CFTR transcripts that lacked exon 9, and (TG)12 gave a sixfold increase, compared with the (TG)10 allele. T5 CFTR genes derived from patients were found to carry a high number of TG repeats, while T5 CFTR genes derived from healthy CF fathers harbored a low number of TG repeats. Moreover, it was found that M470 CFTR proteins matured more slowly, and that they had a 1.7-fold increased intrinsic chloride channel activity compared with V470 CFTR proteins, suggesting that the M470V locus might also play a role in the partial penetrance of T5 as a disease mutation. Such polyvariant mutant genes could explain why apparently normal CFTR genes cause disease. Moreover, they might be responsible for variation in the phenotypic expression of CFTR mutations, and be of relevance in other genetic diseases.

Authors

H Cuppens, W Lin, M Jaspers, B Costes, H Teng, A Vankeerberghen, M Jorissen, G Droogmans, I Reynaert, M Goossens, B Nilius, J J Cassiman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Total
Citations: 1 5 6 3 6 13 5 7 10 12 6 8 11 10 29 14 14 14 21 17 27 22 7 13 10 10 11 3 315
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2008 (14)

Title and authors Publication Year
Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders
SM Moskowitz, JF Chmiel, DL Sternen, E Cheng, RL Gibson, SG Marshall, GR Cutting
Genetics in Medicine 2008
Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: A case-control study in Chinese Han population
D Qiao, L Yi, L Hua, Z Xu, Y Ding, D Shi, L Ni, N Song, Y Wang, H Wu
Journal of Cystic Fibrosis 2008
Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations
E Dequeker, M Stuhrmann, MA Morris, T Casals, C Castellani, M Claustres, H Cuppens, M Georges, C Ferec, M Macek, PF Pignatti, H Scheffer, M Schwartz, M Witt, M Schwarz, E Girodon
European journal of human genetics : EJHG 2008
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice
C Castellani, H Cuppens, M Macek, JJ Cassiman, E Kerem, P Durie, E Tullis, BM Assael, C Bombieri, A Brown, T Casals, M Claustres, GR Cutting, E Dequeker, J Dodge, I Doull, P Farrell, C Ferec, E Girodon, M Johannesson, B Kerem, M Knowles, A Munck, PF Pignatti, D Radojkovic, P Rizzotti, M Schwarz, M Stuhrmann, M Tzetis, J Zielenski, JS Elborn
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2008
Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population
Q Huang, W Ding, MX Wei
World journal of gastroenterology : WJG 2008
Measurement of chloride concentrations of insensible sweat collected from thumb
M NAKAKUKI, H ISHIGURO, K SHIROTA, A YAMAMOTO, SB KO, H GOTO, K FUJIKI, T KONDO, A ENDO, S NARUSE
Suizo 2008
Cystic fibrosis carrier frequency and estimated prevalence of the disease in Morocco
I Ratbi, E Génin, M Legendre, AL Floch, C Costa, S Cherkaoui-Deqqaqi, M Goossens, A Sefiani, E Girodon
Journal of Cystic Fibrosis 2008
TheCFTRM470V Gene Variant as a Potential Modifier of COPD Severity: Study of Serbian Population
M Stankovic, A Nikolic, A Divac, A Tomovic, N Petrovic-Stanojevic, M Andjelic, V Dopudja-Pantic, M Surlan, I Vujicic, D Ponomarev, M Mitic-Milikic, J Kusic, D Radojkovic
Genetic Testing 2008
Exclusive KRAS mutation in microsatellite-unstable human colorectal carcinomas with sequence alterations in the DNA mismatch repair gene, MLH1
Y Zhao, K Miyashita, T Ando, Y Kakeji, T Yamanaka, K Taguchi, T Ushijima, S Oda, Y Maehara
Gene 2008
Molecular analysis of mutations and polymorphisms in the CFTR gene in male infertility
L Tamburino, A Guglielmino, E Venti, S Chamayou
Reproductive BioMedicine Online 2008
Diagnosis of Cystic Fibrosis
KZ Voter, CL Ren
Clinical Reviews in Allergy & Immunology 2008
Multiplex Allele-Specific Fluorescent PCR for Haplotyping the IVS8 (TG)m(T)n Locus in the CFTR Gene
C Costa, JM Costa, J Martin, B Boissier, M Goossens, E Girodon
Clinical chemistry 2008
Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population
Q Huang, W Ding, MX Wei
World journal of gastroenterology : WJG 2008
Association of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation/Variant/Haplotype and Tumor Necrosis Factor (TNF) Promoter Polymorphism in Hyperlipidemic Pancreatitis
YT Chang, MC Chang, TC Su, PC Liang, YN Su, CH Kuo, SC Wei, JM Wong
Clinical chemistry 2008

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 policy sources
Referenced in 1 patents
On 1 Facebook pages
Referenced in 3 clinical guideline sources
94 readers on Mendeley
See more details